IL156720A0 - Process for preparing particles of a substance, particles obtained by the process and pharmaceutical compositions comprising such particles - Google Patents

Process for preparing particles of a substance, particles obtained by the process and pharmaceutical compositions comprising such particles

Info

Publication number
IL156720A0
IL156720A0 IL15672002A IL15672002A IL156720A0 IL 156720 A0 IL156720 A0 IL 156720A0 IL 15672002 A IL15672002 A IL 15672002A IL 15672002 A IL15672002 A IL 15672002A IL 156720 A0 IL156720 A0 IL 156720A0
Authority
IL
Israel
Prior art keywords
particles
liquid
substance
preparing
temperature
Prior art date
Application number
IL15672002A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL156720A0 publication Critical patent/IL156720A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/04—Solvent extraction of solutions which are liquid
    • B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
    • B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15672002A 2001-01-26 2002-01-21 Process for preparing particles of a substance, particles obtained by the process and pharmaceutical compositions comprising such particles IL156720A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0102075.9A GB0102075D0 (en) 2001-01-26 2001-01-26 Process
PCT/GB2002/000261 WO2002058674A2 (en) 2001-01-26 2002-01-22 Process for preparing particles

Publications (1)

Publication Number Publication Date
IL156720A0 true IL156720A0 (en) 2004-01-04

Family

ID=9907591

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15672002A IL156720A0 (en) 2001-01-26 2002-01-21 Process for preparing particles of a substance, particles obtained by the process and pharmaceutical compositions comprising such particles
IL156720A IL156720A (en) 2001-01-26 2003-06-30 Process for making material particles

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL156720A IL156720A (en) 2001-01-26 2003-06-30 Process for making material particles

Country Status (22)

Country Link
US (2) US7108867B2 (xx)
EP (1) EP1357901B1 (xx)
JP (1) JP4175892B2 (xx)
KR (1) KR100853596B1 (xx)
CN (1) CN1298312C (xx)
AT (1) ATE354352T1 (xx)
BR (1) BR0206439A (xx)
CA (1) CA2433838A1 (xx)
CY (1) CY1106550T1 (xx)
DE (1) DE60218285T2 (xx)
DK (1) DK1357901T3 (xx)
ES (1) ES2281509T3 (xx)
GB (1) GB0102075D0 (xx)
HK (1) HK1063157A1 (xx)
IL (2) IL156720A0 (xx)
MX (1) MXPA03006537A (xx)
NO (1) NO20033241L (xx)
NZ (1) NZ526942A (xx)
PT (1) PT1357901E (xx)
SI (1) SI1357901T1 (xx)
WO (1) WO2002058674A2 (xx)
ZA (1) ZA200304953B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB0126716D0 (en) * 2001-11-07 2002-01-02 Advanced Phytonics Ltd Method for the production of particles
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
AU2003297367A1 (en) * 2002-12-19 2004-07-14 Baxter International, Inc. Process for preparing pharmaceutical formulations using supercritical fluids
MXPA05011626A (es) * 2003-04-29 2006-01-23 Akzo Nobel Nv Procedimiento de soldificacion con antisolvente.
EP1624862B1 (en) 2003-05-08 2014-12-31 Nektar Therapeutics Particulate materials
EP1675571A2 (en) * 2003-09-30 2006-07-05 Spherics, Inc. Nanoparticulate therapeutic biologically active agents
US7220456B2 (en) 2004-03-31 2007-05-22 Eastman Kodak Company Process for the selective deposition of particulate material
US7223445B2 (en) 2004-03-31 2007-05-29 Eastman Kodak Company Process for the deposition of uniform layer of particulate material
EP1904219A4 (en) * 2005-07-15 2011-07-27 Map Pharmaceuticals Inc METHOD FOR FORMING PARTICLES
NL1031224C2 (nl) * 2006-02-23 2007-09-03 Friesland Brands Bv Het bereiden van gedroogde deeltjes met behulp van een superkritisch medium.
US20080187568A1 (en) * 2007-02-06 2008-08-07 Sawhney Amarpreet S Polymerization with precipitation of proteins for elution in physiological solution
WO2008097664A1 (en) 2007-02-11 2008-08-14 Map Pharmaceuticals, Inc. Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
JP5307382B2 (ja) * 2007-11-14 2013-10-02 日機装株式会社 微粒子化方法
WO2009072950A1 (en) * 2007-12-07 2009-06-11 Xspray Microparticles Ab Method and arrangement for the production of particles
US9808030B2 (en) 2011-02-11 2017-11-07 Grain Processing Corporation Salt composition
HRP20231060T1 (hr) * 2012-03-22 2023-12-22 Novo Nordisk A/S Pripravci peptida glp-1 i njihova priprava
JP6668652B2 (ja) 2015-09-18 2020-03-18 日本精工株式会社 直動案内装置、直動案内装置用エンドキャップ

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0432232B1 (en) 1989-05-01 1994-01-05 Alkermes Controlled Therapeutics, Inc. Process for producing small particles of biologically active molecules
US5639441A (en) 1992-03-06 1997-06-17 Board Of Regents Of University Of Colorado Methods for fine particle formation
US5346702A (en) * 1992-12-04 1994-09-13 Sterling Winthrop Inc. Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization
GB9313642D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
GB9413202D0 (en) 1994-06-30 1994-08-24 Univ Bradford Method and apparatus for the formation of particles
DE69637441T2 (de) 1995-10-17 2009-03-05 Jagotec Ag Verabreichung unlöslicher arzneistoffe
GB9703673D0 (en) 1997-02-21 1997-04-09 Bradford Particle Design Ltd Method and apparatus for the formation of particles
GB9804379D0 (en) 1998-03-02 1998-04-22 Bradford Particle Design Ltd Method of particle formation
EP1071402B1 (en) * 1998-04-09 2006-09-13 F. Hoffmann-La Roche Ag Process for the manufacture of (sub)micron sized particles by dissolving in compressed gas and surfactants
SE9801287D0 (sv) * 1998-04-14 1998-04-14 Astra Ab Incorporation of active substances in carrier matrixes
GB9810559D0 (en) 1998-05-15 1998-07-15 Bradford Particle Design Ltd Method and apparatus for particle formation
SE9804001D0 (sv) 1998-11-23 1998-11-23 Astra Ab New process
GB9828204D0 (en) 1998-12-21 1999-02-17 Smithkline Beecham Plc Process
GB9915975D0 (en) 1999-07-07 1999-09-08 Bradford Particle Design Ltd Method for the formation of particles
GB9920558D0 (en) 1999-08-31 1999-11-03 Bradford Particle Design Ltd Methods for particle formation and their products
EP1404438A2 (en) * 2001-07-12 2004-04-07 Eastman Kodak Company A surfactant assisted nanomaterial generation process
US6998051B2 (en) * 2002-07-03 2006-02-14 Ferro Corporation Particles from supercritical fluid extraction of emulsion
JP2007516259A (ja) * 2003-12-09 2007-06-21 メッドクリスタルフォームズ、エルエルシー 活性剤との混合相共結晶の調製方法
US7754243B2 (en) * 2004-08-03 2010-07-13 Clemson University Research Foundation Aqueous suspension of nanoscale drug particles from supercritical fluid processing

Also Published As

Publication number Publication date
SI1357901T1 (sl) 2007-08-31
EP1357901A2 (en) 2003-11-05
HK1063157A1 (en) 2004-12-17
KR20030070921A (ko) 2003-09-02
US7829123B2 (en) 2010-11-09
CA2433838A1 (en) 2002-08-01
US20070009604A1 (en) 2007-01-11
NO20033241D0 (no) 2003-07-17
KR100853596B1 (ko) 2008-08-22
ATE354352T1 (de) 2007-03-15
IL156720A (en) 2010-03-28
WO2002058674A3 (en) 2002-11-21
WO2002058674A2 (en) 2002-08-01
ZA200304953B (en) 2004-08-25
CN1487825A (zh) 2004-04-07
AU2002225193B2 (en) 2006-07-27
JP4175892B2 (ja) 2008-11-05
PT1357901E (pt) 2007-05-31
US20040058007A1 (en) 2004-03-25
CN1298312C (zh) 2007-02-07
US7108867B2 (en) 2006-09-19
DE60218285T2 (de) 2007-11-15
BR0206439A (pt) 2003-12-30
NZ526942A (en) 2005-04-29
MXPA03006537A (es) 2003-09-22
ES2281509T3 (es) 2007-10-01
NO20033241L (no) 2003-07-17
DK1357901T3 (da) 2007-06-04
JP2004521891A (ja) 2004-07-22
EP1357901B1 (en) 2007-02-21
GB0102075D0 (en) 2001-03-14
DE60218285D1 (de) 2007-04-05
CY1106550T1 (el) 2012-01-25

Similar Documents

Publication Publication Date Title
IL156720A0 (en) Process for preparing particles of a substance, particles obtained by the process and pharmaceutical compositions comprising such particles
ATE377044T1 (de) Gel auf der basis von polysacchariden
AU2002212412A1 (en) Method for making very fine particles consisting of a principle inserted in a host molecule
EA200601957A1 (ru) Удаление загрязнителей из природного газа с помощью охлаждения
DE602004025782D1 (de) Mikrowellenunterstützte Peptidsynthese
Geiser et al. In-line system containing porous polymer monoliths for protein digestion with immobilized pepsin, peptide preconcentration and nano-liquid chromatography separation coupled to electrospray ionization mass spectroscopy
DK1214058T3 (da) Fremgangsmåde til opnåelse af mikorpartikler
MY143253A (en) Method and device for stripping ammonia from liquids
MY138064A (en) Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
ATE478107T1 (de) Verfahren zur reinigung von polyetherketone mit wasser
BR0304937B1 (pt) composição de antiespumante de silicone encapsulado e processo para a produção de uma composição de antiespumante de silicone encapsulado.
CN105566671A (zh) 一种制备有机-无机杂化多孔整体材料的方法
Williams et al. Rolloamides A and B, cytotoxic cyclic heptapeptides isolated from the Caribbean marine sponge Eurypon laughlini
Iwata et al. Rabbit pulmonary angiotensin-converting enzyme: the NH2-terminal fragment with enzymatic activity and its formation from the native enzyme by NH4OH treatment
CN103926245B (zh) 一种dna修饰的金纳米比色传感器，及其制备方法以及用途
ATE316575T1 (de) Rekombinante mistellektine
BG106842A (en) Human heparanase-related polypeptide and nucleic acid
BR9915484A (pt) Processo para o isolamento contìnuo de proteìnas ativas
Deyrup et al. A new substrate for porcine pepsin possessing cryptic fluorescence properties
ATE498646T1 (de) Verfahren zur herstellung von mikropartikeln
JPS53130054A (en) Orientation treatment method of liquid crystal cells
Hsiao Carboxypeptidase Y: purification, immobilization and applications in protein sequencing and peptide synthesis
Akanuma et al. Ligand Bindings of Bovine Carboxypeptidase B I. Kinetic Studies Using Dipeptide Substrates and Their Carboxyl-Terminal Amino Acid Analogs
Massis Biophysical studies and thermodynamic analysis of cathepsin B interactions
SE0002364D0 (sv) Growth Factors